Target intelligence / Profile preview

Immunoglobulin heavy variable (II)-60-1 (pseudogene)

Molecular classification
Other (Immunoglobulin gene segment, pseudogene)
01

Overview

The immunoglobulin heavy variable (II)-60-1 is a member of the immunoglobulin heavy chain variable (IGHV) gene segment repertoire located within the human immunoglobulin heavy chain locus. It is formally known as a pseudogene, meaning it does not encode a functional protein product. Immunoglobulin heavy chain variable gene segments collectively encode the variable domains of immunoglobulin heavy chains, which together with light chains form antigen-binding sites of antibodies. However, pseudogenes like IGHVII-60-1 are typically not transcribed or translated into functional immunoglobulin proteins, and therefore do not participate in immune recognition or response, nor act as receptors, enzymes, or therapeutic targets. This gene is explicitly listed as a pseudogene by sequence resources and catalogues, and not as a functional protein-coding gene. Immunoglobulin heavy chain variable genes in general are classified by function (protein-coding, expressed in immune response) or as pseudogenes (nonfunctional, not expressed as protein). There is no evidence in available resources that IGHVII-60-1 encodes a receptor, enzyme, transporter, or is a therapeutic target. No disease associations, biomarkers, or drug interactions are documented for this entity. It is not a druggable or therapeutic target and not involved in any known mechanism of action for therapies. In summary, "Immunoglobulin heavy variable (II)-60-1 (pseudogene)" is a nonfunctional gene segment found in the immunoglobulin heavy chain locus, with no known role as a drug target, biomarker, or therapeutic entity. The core premise of considering it as a target or receptor is incorrect.

Other names
IGHVII-60-1IGHV(II)-60-1IGHVII601IGHVII-601IGHV(II)-6014-60.1P

Beyond the preview

Go deeper on Immunoglobulin heavy variable (II)-60-1 (pseudogene).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable (II)-60-1 (pseudogene).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call